HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The immunodominance of RBD antigen of delta variant as vaccine candidate against SARS-CoV-2 infection.

AuthorsDeyan Luo, Tao Li, Xiaolan Yang, Nianzhi Ning, Liangyan Zhang, Hongjing Gu, Deyu Li, Wenjing Yu, Zhongyu Hu, Hui Wang
JournalJournal of medical virology (J Med Virol) Vol. 95 Issue 1 Pg. e28359 (01 2023) ISSN: 1096-9071 [Electronic] United States
PMID36448090 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Neutralizing
  • Spike Glycoprotein, Coronavirus
  • Antibodies, Viral
  • spike protein, SARS-CoV-2
Topics
  • Humans
  • COVID-19 (prevention & control)
  • SARS-CoV-2 (genetics)
  • Antibodies, Neutralizing
  • Spike Glycoprotein, Coronavirus (genetics)
  • Antibodies, Viral

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: